X4 Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Corporate Update

Go back to X4 Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Corporate Update
(NASDAQ: XFOR) Delayed: 4.22 --0 (-0%)
Previous Close $4.22    52 Week High
Open $4.22    52 Week Low
Day High $4.22    P/E N/A 
Day Low $4.22    EPS
Volume